Royalty Pharma plc Aktie

Watchlist RPRX ISIN US76028H2094

Was macht Royalty Pharma plc?

Unternehmensprofil
Unternehmensprofil

Repros Therapeutics Inc. ® was organized on August 20, 1987. We are a development stage biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

Chart der Royalty Pharma plc Aktie

Charttool öffnen